Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · IEX Real-Time Price · USD
1.225
-0.045 (-3.54%)
Jul 12, 2024, 12:59 PM EDT - Market open

Akebia Therapeutics Market Cap

Akebia Therapeutics has a market cap or net worth of $254.66 million as of July 12, 2024. Its market cap has increased by 56.91% in one year.

Market Cap
254.66M
Enterprise Value
262.01M
1-Year Change
56.91%
Ranking
Category
Stock Price
$1.23

Market Cap Chart

Since March 20, 2014, Akebia Therapeutics's market cap has decreased from $488.10M to $254.66M, a decrease of -47.83%. That is a compound annual growth rate of -6.11%.

History

DateMarket Cap% Change
Jul 11, 2024266.20M13.96%
Dec 29, 2023233.60M120.17%
Dec 30, 2022106.10M-73.17%
Dec 31, 2021395.40M-2.30%
Dec 31, 2020404.70M-46.16%
Dec 31, 2019751.70M138.26%
Dec 31, 2018315.50M-55.11%
Dec 29, 2017702.90M76.17%
Dec 30, 2016399.00M0.81%
Dec 31, 2015395.80M67.15%
Dec 31, 2014236.80M-51.49%
Mar 20, 2014488.10M-
View and export this data all the way back to 2014. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Tenaya Therapeutics 274.81M
Accolade 273.63M
CorMedix 269.85M
Q32 Bio 267.98M
Nanobiotix 267.12M
LifeMD 261.40M
Zevra Therapeutics 255.72M
Viemed Healthcare 255.44M
Market Cap Rankings